
Houston Chronicle Features Dr. James Martin’s Congenital Heart Disease Research
Congenital heart disease (CHD) – a spectrum of heart defects that develop before birth – can lead to pediatric heart...
Congenital heart disease (CHD) – a spectrum of heart defects that develop before birth – can lead to pediatric heart...
THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...
Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...
Texas Heart Institute’s Rich Gang Li, PhD, recently earned the award for “Best Oral Presentation” for his platform talk at...
The impact of a scientific article is often described in terms of how many times the article has been cited...
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
The New Paper Follows Closely on the Heels of a Related Publication on Cardiomyocyte Renewal Following a Heart Attack ...
Patients suffering from heart failure have very limited treatment options, and up to this point, it had essentially been impossible...
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
Heart failure impacts 26 million people around the world and remains one of the most devastating heart conditions today. Our...
Dr. James Martin, Director of Texas Heart Institute’s Cardiomyocyte Renewal Laboratory, and his team’s research on genetic pathways have led to...
Researchers in the Texas Heart Institute’s Cardiomyocyte Renewal Laboratory are a step closer to possibly restoring the regenerative properties of...